EP
ASMB icon

Eversept Partners’s Assembly Biosciences ASMB Stock Holding History

Eversept Partners’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$454K Sell
16,510
-24,379
-60% -$664K 0.02% 116
2026
Q1 		$1.13M Sell
40,889
-118,787
-74% -$3.39M 0.06% 103
2025
Q4 		$5.43M Buy
+159,676
New +$5.14M 0.27% 68
2022
Q2 		– Sell
-23,333
Closed -$577K – 80
2022
Q1 		$577K Sell
23,333
-2,500
-10% -$53.7K 0.04% 72
2021
Q4 		$722K Sell
25,833
-3,334
-11% -$109K 0.05% 94
2021
Q3 		$1.22M Buy
+29,167
New +$1.22M 0.08% 91

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Eversept Partners's ASMB Position: Q2 2026 in Review

Eversept Partners reduced its Assembly Biosciences (ASMB) stake by 60% in Q2 2026, selling an estimated $664K and leaving 16,510 shares worth $454K. The position accounts for 0.02% of the portfolio, ranked #116.

Eversept Partners first reported a position in ASMB in Q3 2021 and has held it in 6 quarters since. The position peaked at $5.43M in Q4 2025. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Eversept Partners held 16,510 shares of Assembly Biosciences worth $454K as of Q2 2026.
  • Eversept Partners sold 24,379 Assembly Biosciences shares in Q2 2026, an estimated $664K.
  • Assembly Biosciences made up 0.02% of Eversept Partners's portfolio in Q2 2026, its #116 holding.
  • Eversept Partners first reported a position in Assembly Biosciences in Q3 2021 and has held it in 6 quarters since.
  • Eversept Partners's Assembly Biosciences position peaked at $5.43M in Q4 2025.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.